Skip to main content

AMGEN INC

CIK 0000318154

AMGNNasdaqBiological Products, (No Diagnostic Substances) (SIC 2836)Fiscal year ends in late December

Fiscal 2025

From the 10-K filed 2026-02-13, year ended 2025-12-31

Revenue

$36.75B

Up 10.0% on 2024

Net income

$7.71B

Up 88.5% on 2024

Operating income

$9.08B

As reported

Diluted EPS

$14.23

Per share, as reported

Free cash flow

$8.10B

Calculated

Free cash flow is not a line in the filing. It is calculated as operating cash flow minus capital expenditures for the same year. Revenue uses the tag RevenueFromContractWithCustomerExcludingAssessedTax.

Six years of revenue and net income

RevenueNet income

Every year, with its filing

US dollars in millions. Each accession number opens the filing on sec.gov.
Fiscal yearRevenueNet incomeFormFiled
202536,7517,71110-K2026-02-13
202433,4244,09010-K2025-02-14
202328,1906,71710-K2024-02-14
202226,3236,55210-K2023-02-09
202125,9795,89310-K2022-02-16
202025,4247,26410-K2022-02-16

Get these numbers yourself

The shared demo key works for a quick try. A free key gives 100 calls a day, and agents can pay 0.02 USDC a call with x402.

Read the API docs

curl

curl -H "Authorization: Bearer demo" \
  "https://api.netnestdesign.com/v1/history/AMGN/revenue?period=annual&limit=6"

Python

import requests

r = requests.get(
    "https://api.netnestdesign.com/v1/fundamentals/AMGN",
    params={"metrics": "revenue,net_income,eps_diluted", "period": "annual"},
    headers={"Authorization": "Bearer demo"},
    timeout=30,
)
for row in r.json()["data"]:
    print(row["metric"], row["value"], row["form"], row["filed_date"])

Data from SEC filings. Not investment advice.